Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014 (2014), Article ID 398147, 12 pages
http://dx.doi.org/10.1155/2014/398147
Research Article

Detecting Epistatic Interactions in Metagenome-Wide Association Studies by metaBOOST

MOE Key Laboratory of Bioinformatics, Bioinformatics Division and Center for Synthetic & Systems Biology, TNLIST, Department of Automation, Tsinghua University, Beijing 100084, China

Received 14 June 2014; Accepted 14 July 2014; Published 24 July 2014

Academic Editor: Hao-Teng Chang

Copyright © 2014 Mengmeng Wu and Rui Jiang. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Manichanh, L. Rigottier-Gois, E. Bonnaud et al., “Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach,” Gut, vol. 55, no. 2, pp. 205–211, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Qin, Y. Li, Z. Cai et al., “A metagenome-wide association study of gut microbiota in type 2 diabetes,” Nature, vol. 490, no. 7418, pp. 55–60, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Greenblum, P. J. Turnbaugh, and E. Borenstein, “Metagenomic systems biology of the human gut microbiome reveals topological shifts associated with obesity and inflammatory bowel disease,” Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 2, pp. 594–599, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. I. Cho and M. J. Blaser, “The human microbiome: at the interface of health and disease,” Nature Reviews Genetics, vol. 13, no. 4, pp. 260–270, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. J. M. Kinross, A. W. Darzi, and J. K. Nicholson, “Gut microbiome-host interactions in health and disease,” Genome Medicine, vol. 3, no. 3, article 14, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. J. C. Wooley, A. Godzik, and I. Friedberg, “A primer on metagenomics,” PLoS Computational Biology, vol. 6, no. 2, Article ID e1000667, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. The Human Microbiome Project Consortium, “Structure, function and diversity of the healthy human microbiome,” Nature, vol. 486, no. 7402, pp. 207–214, 2012. View at Publisher · View at Google Scholar
  8. S. D. Ehrlich, “MetaHIT: The European Union Project on metagenomics of the human intestinal tract,” in Metagenomics of the Human Body, pp. 307–316, Springer, 2011. View at Google Scholar
  9. M. Arumugam, J. Raes, E. Pelletier et al., “Enterotypes of the human gut microbiome,” Nature, vol. 473, no. 7346, pp. 174–180, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. K. Lê, Y. Li, X. Xu et al., “Alterations in fecal Lactobacillus and Bifidobacterium species in type 2 diabetic patients in Southern China population,” Frontiers in Physiology, vol. 3, Article ID Article 496, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. N. Larsen, F. K. Vogensen, F. W. J. van den Berg et al., “Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults,” PLoS ONE, vol. 5, no. 2, Article ID e9085, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. P. J. Turnbaugh, R. E. Ley, M. A. Mahowald, V. Magrini, E. R. Mardis, and J. I. Gordon, “An obesity-associated gut microbiome with increased capacity for energy harvest,” Nature, vol. 444, no. 7122, pp. 1027–1031, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. H. J. Cordell, “Epistasis: what it means, what it doesn't mean, and statistical methods to detect it in humans,” Human Molecular Genetics, vol. 11, no. 20, pp. 2463–2468, 2002. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Nelson, S. Kardia, R. Ferrell, and C. Sing, “A combinatorial partitioning method to identify multilocus genotypic partitions that predict quantitative trait variation,” Genome Research, vol. 11, no. 3, pp. 458–470, 2001. View at Google Scholar
  15. M. D. Ritchie, L. W. Hahn, N. Roodi et al., “Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer,” The American Journal of Human Genetics, vol. 69, no. 1, pp. 138–147, 2001. View at Publisher · View at Google Scholar · View at Scopus
  16. R. Jiang, W. Tang, X. Wu, and W. Fu, “A random forest approach to the detection of epistatic interactions in case-control studies,” BMC Bioinformatics, vol. 10, no. 1, article S65, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. Y. Zhang and J. S. Liu, “Bayesian inference of epistatic interactions in case-control studies,” Nature Genetics, vol. 39, no. 9, pp. 1167–1173, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. W. Tang, X. Wu, R. Jiang, and Y. Li, “Epistatic module detection for case-control studies: A Bayesian model with a Gibbs sampling strategy,” PLoS Genetics, vol. 5, no. 5, Article ID e1000464, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. X. Wan, C. Yang, Q. Yang et al., “BOOST: a fast approach to detecting gene-gene interactions in genome-wide case-control studies,” The American Journal of Human Genetics, vol. 87, no. 3, pp. 325–340, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. L. S. Yung, C. Yang, X. Wan, and W. Yu, “GBOOST: a GPU-based tool for detecting gene-gene interactions in genome-wide case control studies,” Bioinformatics, vol. 27, no. 9, pp. 1309–1310, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. Y. M. Cho, M. D. Ritchie, J. H. Moore et al., “Multifactor-dimensionality reduction shows a two-locus interaction associated with type 2 diabetes mellitus,” Diabetologia, vol. 47, no. 3, pp. 549–554, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. T. D. Howard, G. H. Koppelman, J. Xu et al., “Gene-gene interaction in asthma: Il4ra and il13 in a dutch population with asthma,” American Journal of Human Genetics, vol. 70, no. 1, pp. 230–236, 2002. View at Publisher · View at Google Scholar · View at Scopus
  23. Ö. Carlborg and C. S. Haley, “Epistasis: too often neglected in complex trait studies?” Nature Reviews Genetics, vol. 5, no. 8, pp. 618–625, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. Y. Wang, G. Liu, M. Feng, and L. Wong, “An empirical comparison of several recent epistatic interaction detection methods,” Bioinformatics, vol. 27, no. 21, pp. 2936–2943, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. J. Shang, J. Zhang, Y. Sun, D. Liu, D. Ye, and Y. Yin, “Performance analysis of novel methods for detecting epistasis,” BMC Bioinformatics, vol. 12, article 475, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. D. R. Velez, B. C. White, A. A. Motsinger et al., “A balanced accuracy function for epistasis modeling in imbalanced datasets using multifactor dimensionality reduction,” Genetic Epidemiology, vol. 31, no. 4, pp. 306–315, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. J. Qin, R. Li, J. Raes et al., “A human gut microbial gene catalogue established by metagenomic sequencing,” Nature, vol. 464, no. 7285, pp. 59–65, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. R. Luo, B. Liu, Y. Xie et al., “OAPdenovo2: an empirically improved memory-efficient short-read de novo assembler,” Gigascience, vol. 1, no. 1, article 18, 2012. View at Google Scholar
  29. H. Noguchi, J. Park, and T. Takagi, “MetaGene: prokaryotic gene finding from environmental genome shotgun sequences,” Nucleic Acids Research, vol. 34, no. 19, pp. 5623–5630, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. D. C. Richter, F. Ott, A. F. Auch, R. Schmid, and D. H. Huson, “MetaSim—a sequencing simulator for genomics and metagenomics,” PLoS ONE, vol. 3, no. 10, Article ID e3373, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. X. Xu, H. Hui, and D. Cai, “Differences in fecal Bifidobacterium species between patients with type 2 diabetes and healthy individuals,” Nan Fang Yi Ke Da Xue Xue Bao, vol. 32, no. 4, pp. 531–564, 2012 (Chinese). View at Google Scholar · View at Scopus
  32. P. D. Cani, A. M. Neyrinck, F. Fava et al., “Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia,” Diabetologia, vol. 50, no. 11, pp. 2374–2383, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. Y. Zheng, N. Ma, X. Hu, and L. Zhang, “Effect of actinobacillus actinomycetem on the secretion of interleukin-6 and apoptosis rate of polymorphonuclear leukocyte in type 2 diabetes patients,” West China Journal of Stomatology, vol. 29, no. 3, pp. 286–288, 2011. View at Google Scholar
  34. I. Mukhopadhya, R. Hansen, E. M. El-Omar, and G. L. Hold, “IBD—what role do Proteobacteria play?” Nature Reviews Gastroenterology and Hepatology, vol. 9, no. 4, pp. 219–230, 2012. View at Publisher · View at Google Scholar · View at Scopus